JPH0499759A - (e)-2-alken-4-ynyl sulfonate derivative and production thereof - Google Patents

(e)-2-alken-4-ynyl sulfonate derivative and production thereof

Info

Publication number
JPH0499759A
JPH0499759A JP21852990A JP21852990A JPH0499759A JP H0499759 A JPH0499759 A JP H0499759A JP 21852990 A JP21852990 A JP 21852990A JP 21852990 A JP21852990 A JP 21852990A JP H0499759 A JPH0499759 A JP H0499759A
Authority
JP
Japan
Prior art keywords
formula
group
compound
lower alkyl
alken
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP21852990A
Other languages
Japanese (ja)
Inventor
Masahiro Hayashi
正弘 林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MSD KK
Original Assignee
Banyu Phamaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Phamaceutical Co Ltd filed Critical Banyu Phamaceutical Co Ltd
Priority to JP21852990A priority Critical patent/JPH0499759A/en
Publication of JPH0499759A publication Critical patent/JPH0499759A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

NEW MATERIAL:An (E)-alken-4-ynyl sulfonate derivative shown by formula I (R is lower alkyl, phenyl or p-tolyl; R<1> is H, lower alkyl, lower alkoxy or phenyl ; R<2> and R<3> may be the same or different H, lower alkyl or both R<2> and R<3> are bonded to form lower alkylene). EXAMPLE:(E)-6,6-Dimethyl-2-hepten-4-ynl methanesulfonate. USE:Useful as an intermediate for producing drugs such as an agent for alleviating hyperlipemia, antifungal agent, etc. PREPARATION:An alcohol shown by formula II is reacted with a compound shown by formula III in the presence of a base by using preferably equimolar amount, or a little excessive amount based on the compound shown by formula II of a compound shown by formula III in a solvent such as butyl acetate to give a compound shown by formula TV. Then this compound is subjected to intramolecular rearrangement to give a compound shown by formula I.

Description

【発明の詳細な説明】 r棗上二且且医1 本発明は、新規なスルホナート誘導体に関し、更に詳し
くは、医薬の分野、特には抗高脂血症剤又は抗真菌剤等
の医薬品を製造する際の中間体として有用な(E)−2
−アルケン−4−イニルスルホナート誘導体及びその製
造法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel sulfonate derivative, more particularly to the field of medicine, particularly for the production of pharmaceuticals such as antihyperlipidemic agents or antifungal agents. (E)-2 useful as an intermediate in
-Alken-4-ynylsulfonate derivatives and methods for producing the same.

の   び  が  しよ−と る 本発明は各種医薬品を製造する際の中間体として有用な
、下記の一武威CI]で表される新規な(E)−2−ア
ルケン−4−イニルスルホナート誘導体並びにその製造
法を提供するものである。
The present invention is directed to a novel (E)-2-alken-4-ynylsulfonate represented by Ichibui CI below, which is useful as an intermediate in the production of various pharmaceuticals. The present invention provides derivatives and methods for producing the same.

U式中、Rは低級アルキル基、フェニル基又はp−1−
リル基を示し、R1は水素原子、低級アルキル基、低級
アルコキシ基又はフェニル基を示し、また、R2及びR
3は同−若しくは異なって水素原子又は低級アルキル基
を示すか或いは両者が一緒になって低級アルキレン基を
示す] 本発明により提供される上記−武威[I]の化合物は、
近年抗高脂血症剤又は抗真菌剤製造のための中間原料と
してその価値が認められている。[サイエンス(Sci
ence)、第224巻、1239頁(1984年)、
特願昭63−296840号公報参照]。式[11の化
合物に関連する従来の技術としては、その構造類似体と
して、2−ペンテン−4−イニルメタンスルホナート及
び2−アルケン−4−イニルプロミド誘導体が知られて
いる[ジャーナル・オブ・ケミカル・ソサエティ・パー
キン・トランザクション(J、 Chem、 Sac、
 、 Perkin Trans、 )。
In the U formula, R is a lower alkyl group, a phenyl group, or p-1-
R1 represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, or a phenyl group, and R2 and R
3 are the same or different and represent a hydrogen atom or a lower alkyl group, or both together represent a lower alkylene group] The compound of the above-Wuwei [I] provided by the present invention is:
In recent years, its value has been recognized as an intermediate raw material for the production of antihyperlipidemic agents or antifungal agents. [Science
ence), Vol. 224, p. 1239 (1984),
See Japanese Patent Application No. 63-296840]. In the prior art related to the compound of formula [11], 2-penten-4-ynyl methanesulfonate and 2-alken-4-ynyl bromide derivatives are known as its structural analogs [Journal of Chemical Society Perkin Transactions (J, Chem, Sac,
, Perkin Trans, ).

1981年、553頁;アンゲバンテ・ケミ−・インタ
ーナショナル・エデイジョン・イン・イングリッシュ(
Angew、 Chem、 Int、 Ed、 Eng
l、 )第26巻、320頁(1987年)特開昭57
−142991号公報参照]。こ参照化合物は非対称の
二重結合を有するためE(トランス)一体若しくはZ(
ンス)一体の単一又は混合物として存在するが、これら
幾何異性体の分離及び単一異性体の入手は従来非常に困
難であった。即ち、上記文献中で知られている(E)−
2−ペンテン−4−イニルメタンスルホナートは、(E
)−2−ペンテン−4−イニルアルコールのメンル化に
より製造され得るが、この原料アルコールの人手には液
体アンモニアを溶媒とする煩雑で非経済的な操作を必要
とする[ジャーナル・オブ・ケミカル・ソサエティ(J
、Chem、Soc、)、1947年、1583頁参照
]。また、その他に知られている2アルケン−4−イニ
ルプロミド誘導体は全てE一体及びZ一体の混合物とし
て取扱われ、その分離には分取ガスクロマトグラフィー
等の非工業的で特殊な分離手段が必要である。
1981, 553 pages; Angewante Chemie International Edition in English (
Angew, Chem, Int, Ed, Eng
l, ) Vol. 26, p. 320 (1987) Japanese Patent Application Publication No. 1987
-Refer to Publication No. 142991]. This reference compound has an asymmetric double bond, so it is either E (trans) monolithic or Z(
Although these geometric isomers exist as a single entity or as a mixture, it has been extremely difficult to separate these geometric isomers and obtain a single isomer. That is, the (E)-
2-penten-4-ynyl methanesulfonate is (E
)-2-penten-4-ynyl alcohol, but the manual preparation of this raw alcohol requires complicated and uneconomical operations using liquid ammonia as a solvent [Journal of Chemical・Society (J
, Chem, Soc, 1947, p. 1583]. In addition, all other known 2-alken-4-ynyl bromide derivatives are treated as a mixture of E and Z, and their separation requires non-industrial special separation means such as preparative gas chromatography. be.

本発明の目的は、これら関連する化合物の従来の製造法
を改良し、安価で簡便な(E)−2−アルケン−4−イ
ニルスルホナートx導体の工業的製法を提供することに
ある。
An object of the present invention is to provide an inexpensive and simple industrial method for producing (E)-2-alkene-4-ynylsulfonate x conductors by improving the conventional production methods for these related compounds.

−2′  るための 本発明者らは、容易に入手できる原料である一般式 %式%[1] [式中、R’、R2及びR3は前記の意味を有する]で
表されるアルコール誘導体を原料とし、目的の(E)2
−アルケン−4−イニルスルホナート誘導体[I]を製
造する方法を種々検討した結果、−武威[II]のアル
コール誘導体に、塩基の存在下、−武威%式%[] [式中、Rは前記の意味を有する]で表される化合物を
反応させて、−武威 [式中、R,R’、 R’及びR3は前記の意味を有す
る]で表される化合物を得、次いでこれを分子内転移さ
せることにより、−武威[I]で表される(E)−2−
アルケン−4−イニルスルホナート誘導体が、極めて簡
便に、且つ高収率で得られることを見出した。
-2' The present inventors have developed an alcohol derivative represented by the general formula % [1] [wherein R', R2 and R3 have the above-mentioned meaning], which is an easily available raw material. as the raw material, the objective (E)2
- As a result of examining various methods for producing the alkene-4-ynyl sulfonate derivative [I], it was found that - an alcohol derivative of - Wuyi [II] was added to the alcohol derivative of - Wuyi [II] in the presence of a base, - Wuyi % formula % [] [wherein R have the meanings given above] to obtain a compound represented by -Wuwei [wherein R, R', R' and R3 have the meanings given above], which is then reacted with By intramolecular transfer, (E)-2- represented by -Wuwei [I]
It has been found that alkene-4-ynylsulfonate derivatives can be obtained extremely easily and in high yields.

更に発明者らは、上記製法で得られた(E)−2−アル
ケン−4−イニルスルホナート誘導体[I]が、各種医
薬品を製造する際の合成中間体として十分な純度と反応
性を具え、従って、同様な目的で使用される従来の中間
体やその製造法に比べて格段に優れた原料中間体となり
得ることを発見し本発明を完成させた。
Furthermore, the inventors have found that the (E)-2-alken-4-ynylsulfonate derivative [I] obtained by the above production method has sufficient purity and reactivity as a synthetic intermediate for producing various pharmaceuticals. The inventors have completed the present invention by discovering that the present invention can be used as a raw material intermediate that is significantly superior to conventional intermediates and their production methods used for similar purposes.

この反応で使用される原料化合物のアルコール体[11
]は、例えば文献記載の下記の製法[ジャーナル・オブ
・メディシナル・ケミストリー(J、MedCheIl
l、 ) 、第27巻、 1539頁(1984年);
特開昭58−208252号公報参照]により容易に製
造することができる。
Alcohol form of the starting compound used in this reaction [11
], for example, according to the following manufacturing method described in the literature [Journal of Medicinal Chemistry (J, MedCheIl.
l, ), Vol. 27, p. 1539 (1984);
JP-A No. 58-208252].

jul+ [式中、R1、R2及びR3は前記の意味を有する]次
に、この明細書の記載において言及される各種用語の定
義及びその具体的な例について説明する。
jul+ [In the formula, R1, R2 and R3 have the above-mentioned meanings] Next, definitions of various terms mentioned in the description of this specification and specific examples thereof will be explained.

「低級」なる語は、この語が付された基又は化合物の炭
素原子数が6個以下、好ましくは4個以下であることを
意味するのに用いる。
The term "lower" is used to mean that the group or compound to which this term is attached has no more than 6 carbon atoms, preferably no more than 4 carbon atoms.

従って低級アルキル基としては、例えばメチル基、エチ
ル基、プロピル基、イソプロピル基、ブチル基、イソブ
チル基、5ec−ブチル基、tert−ブチル基等の炭
素数1〜4個の直鎖又は分枝状のアルキル基が挙げられ
、低級アルコキシ基としては、メトキシ基、エトキシ基
、プロポキシ基、イソプロポキシ基、ブトキシ基、イソ
ブトキシ基、5ec−ブトキシ基又はtert−ブトキ
シ基等の炭素数1〜4個の直鎖又は分枝状のアルコキシ
基が挙げられる。
Therefore, as a lower alkyl group, for example, a linear or branched group having 1 to 4 carbon atoms such as a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, an isobutyl group, a 5ec-butyl group, a tert-butyl group, etc. Examples of lower alkoxy groups include those having 1 to 4 carbon atoms such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, 5ec-butoxy, or tert-butoxy. Straight-chain or branched alkoxy groups may be mentioned.

塩基とは、トリメチルアミン、トリエチルアミン、ピリ
ジン、N、N−ジメチルアニリン、4−ジメチルアミノ
ピリジン等の3級の有機アミン類又は水酸化カリウム、
水酸化ナトリウム、炭酸水素カリウム、炭酸水素ナトリ
ウム、炭酸カリウム、炭酸ナトリウム等の無機塩基を意
味する。
Bases include tertiary organic amines such as trimethylamine, triethylamine, pyridine, N,N-dimethylaniline, and 4-dimethylaminopyridine, or potassium hydroxide;
It refers to inorganic bases such as sodium hydroxide, potassium hydrogen carbonate, sodium hydrogen carbonate, potassium carbonate, and sodium carbonate.

上記アルコール誘導体[11]に、塩基の存在下−武威
[I[1]の化合物を反応させて、−武威[IV]で表
される化合物を得る工程は、通常、反応に関与しない溶
媒中、上記に例示した有機アミン類又は無機塩基類を用
いて行われる。反応に使用される各原料化合物の割合は
、通常、アルコール誘導体[11]に対して化合物[I
I[]は等モル若しくは少過剰モル、また、塩基は等モ
ルから過剰モル、好ましくは1〜3倍モルである。この
際使用される溶媒は、例えばクロロホルム、塩化メチレ
ン等のハロゲン化炭化水素類、ベンゼン、トルエン等の
芳香族炭化水素類、エチルエーテル、テトラヒドロフラ
ン等のエーテル類、酢酸エチル、酢酸ブチル等の有機酸
エステル類が好ましい。反応温度及び反応時間は、−8
0°C〜1006C,1分〜3日間の範囲で任意である
が、好ましくは一206C〜50℃、IO分〜10時間
の範囲である。
The step of reacting the above alcohol derivative [11] with the compound of -Muwei [I[1] in the presence of a base to obtain the compound represented by -Muwei [IV] is usually carried out in a solvent that does not participate in the reaction. This is carried out using the organic amines or inorganic bases exemplified above. The ratio of each raw material compound used in the reaction is usually 1% to 1% alcohol derivative [11] to 1% alcohol derivative [11].
I[] is an equimolar amount or a slight excess molar amount, and the base is an equimolar amount to an excess molar amount, preferably 1 to 3 times the molar amount. Solvents used at this time include, for example, halogenated hydrocarbons such as chloroform and methylene chloride, aromatic hydrocarbons such as benzene and toluene, ethers such as ethyl ether and tetrahydrofuran, and organic acids such as ethyl acetate and butyl acetate. Esters are preferred. The reaction temperature and reaction time are -8
The temperature is arbitrary within the range of 0°C to 1006C, 1 minute to 3 days, but preferably 1206C to 50°C, 10 minutes to 10 hours.

次に、上記で得られた一般式[IV]の化合物を分子内
転移させて一般式[1]で表される(E)−2アルケン
−4−イニルスルホナート誘導体を得る工程は、通常、
反応に関与しない溶媒中、室温又は加温下に暫時放置す
るだけの簡便な操作により容易に達成される。またこの
ことから、該転移反応をアルコール誘導体[11]を化
合物[rV]へ変換する上記の工程と同一の反応系で引
き続いて実施することも可能である。反応に使用される
溶媒としては、上記の工程と同一の反応系で実施される
場合は、通常、先の反応系で使用された溶媒がそのまま
使用されるが、化合物[IV]を一旦単離後に転移させ
る場合は、通常、クロロホルム、塩化メチレン等のハロ
ゲン化炭化水素類、ジメチルホルムアミド若しくはジメ
チルスルホキシド又はそれ等と他の有機溶媒との混合物
等が好ましい。
Next, the step of intramolecularly rearranging the compound of the general formula [IV] obtained above to obtain the (E)-2 alkene-4-ynyl sulfonate derivative represented by the general formula [1] is usually carried out. ,
This can be easily achieved by simply leaving the reaction at room temperature or under heating in a solvent that does not participate in the reaction. Moreover, from this, it is also possible to carry out the rearrangement reaction successively in the same reaction system as the above step of converting the alcohol derivative [11] to the compound [rV]. As for the solvent used in the reaction, when the reaction is carried out in the same reaction system as in the above step, the solvent used in the previous reaction system is usually used as is, but once compound [IV] is isolated, In the case of subsequent transfer, chloroform, halogenated hydrocarbons such as methylene chloride, dimethylformamide or dimethylsulfoxide, or mixtures thereof with other organic solvents are generally preferred.

上記反応により得られる本発明の目的化合物[I]は、
不要の幾何異性体である(Z)一体を殆ど含有せず、従
って抽出、分液、濃縮、蒸留、カラムクロマトグラフィ
ー等の通常の処理により容易に単離・精製することが可
能である。
The target compound [I] of the present invention obtained by the above reaction is:
It contains almost no unnecessary geometric isomer (Z), and therefore can be easily isolated and purified by conventional treatments such as extraction, separation, concentration, distillation, and column chromatography.

また、こうして得られた本発明化合物[11は抗高脂血
症剤、抗真菌剤等の医薬品を製造する際の合成中間体と
して非常に有用である。即ち、本発明化合物[I]はそ
のまま、或いは不活性溶媒中、臭化水素酸、臭化ナトリ
ウム、臭化カリウム、ヨウ化ナトリウム、ヨウ化カリウ
ム又はトリエチルアミンの臭化水素酸塩等を作用させて
そのスルホナート残基を他のハロゲン残基に置換した後
、各種のアミン類に対して通常のアルキル化反応を行え
ば、トランス・エン−イン(trans en−yne
)の部分構造を有するアミン類が容易に製造できる。こ
うした反応により得られるアミン類には、先の参考文献
に開示された抗真菌剤や抗高脂血症剤を挙げることがで
きる。
Furthermore, the thus obtained compound of the present invention [11] is very useful as a synthetic intermediate in the production of pharmaceuticals such as antihyperlipidemic agents and antifungal agents. That is, the compound [I] of the present invention can be used as it is, or by reacting with hydrobromic acid, sodium bromide, potassium bromide, sodium iodide, potassium iodide, triethylamine hydrobromide, etc. in an inert solvent. After substituting the sulfonate residue with another halogen residue, if a normal alkylation reaction is performed on various amines, trans en-yne (trans en-yne) is formed.
) can be easily produced. The amines obtained by such reactions include the antifungal agents and antihyperlipidemic agents disclosed in the above references.

以下、本発明の化合物及びその製造法を実施例により詳
細に説明する。
EXAMPLES Hereinafter, the compound of the present invention and the method for producing the same will be explained in detail with reference to Examples.

実施例1 間撹拌し、析出したトリエチルアミン塩酸塩を濾別する
。濾液を減圧濃縮後、得られた粗製の4,4ジメチル−
1−(2−プロペニル)−2−ペンチニルメタンスルホ
ナートを塩化メチレン30m1に溶解し、室温で15時
間放置する。反応液を5%炭酸水素ナトリウム水溶液及
び飽和食塩水で順次洗浄後無水硫酸マグネシウムにより
乾燥し、溶媒を減圧留去すると、無色油状の表題化合物
11.8g(収率94%)が得られる。
Example 1 After stirring for a while, the precipitated triethylamine hydrochloride was filtered off. After concentrating the filtrate under reduced pressure, the obtained crude 4,4 dimethyl-
1-(2-propenyl)-2-pentynyl methanesulfonate is dissolved in 30 ml of methylene chloride and left at room temperature for 15 hours. The reaction solution was washed successively with a 5% aqueous sodium bicarbonate solution and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was distilled off under reduced pressure to obtain 11.8 g (yield 94%) of the title compound as a colorless oil.

H−NMR(C[1CII)δ:1.24(9H,s)
、 3.02(3H,s)、 4.72(2)1dd、
 J’6.5Hz、 1.2Hz) 、 5.83(I
H,dt、 J=15.7Hz、 1.287.) 。
H-NMR (C[1CII) δ: 1.24 (9H, s)
, 3.02(3H,s), 4.72(2)1dd,
J'6.5Hz, 1.2Hz), 5.83(I
H, dt, J=15.7Hz, 1.287. ).

6、07 (I)l、 dt、 J−15,7Hz、 
6.5Hz)実施例2 6ローノメチルーl−へブテン−4−イン−3−オール
80g及び塩化メタンスルホニル4.8mlをジエチル
エーテル50m/に溶解し、水冷撹拌下トリエチルアミ
ン8.8mlのジエチルエーテル溶液(24ml )を
10分間を要して滴下する。滴下終了後、反応液を室温
で2時6.6−シメチルー1−オクテン−4−イン−3
−オール0.25gをジエチルエーテル20 mlに溶
解し、塩化メタンスルホニル0.15m/とトリエチル
アミン0.3mlを加えて室温で1時間撹拌する。析出
したトリエチルアミン塩酸塩を濾別後、濾液に塩化メチ
レン15m1を加え、室温で24時間放置する。反応液
を飽和食塩水で洗浄後溶媒を留去すると、無色油状の表
題化合物0.35!7 (収率92%)が得られる。
6,07 (I)l, dt, J-15,7Hz,
6.5Hz) Example 2 80g of 6-lonomethyl-l-hebuten-4-yn-3-ol and 4.8ml of methanesulfonyl chloride were dissolved in 50ml of diethyl ether, and a solution of 8.8ml of triethylamine in diethyl ether ( 24 ml) was added dropwise over 10 minutes. After completion of the dropwise addition, the reaction solution was diluted with 6.6-dimethyl-1-octen-4-yn-3 at room temperature for 2 hours.
0.25 g of -ol is dissolved in 20 ml of diethyl ether, 0.15 ml of methanesulfonyl chloride and 0.3 ml of triethylamine are added, and the mixture is stirred at room temperature for 1 hour. After filtering off the precipitated triethylamine hydrochloride, 15 ml of methylene chloride was added to the filtrate, and the mixture was left at room temperature for 24 hours. After washing the reaction solution with saturated brine, the solvent is distilled off to obtain 0.35!7 (yield: 92%) of the title compound as a colorless oil.

H−NMR(CDCL)δ:0.95(3H,t、 J
=7.0llz)、 1.18(6H,s)。
H-NMR (CDCL) δ: 0.95 (3H, t, J
=7.0llz), 1.18(6H,s).

1、47(2H,q、 J−7,0Hz)、 3. (
II (3)1. s)、 4.72(2H,d、 J
+:6、5Hz)、 5.84(IH,d、 J=15
.5t(z) 6.11(1B、 dt J=15.5
Hz、 6.5Hz) 実施例3 6−メチル−6−フェニル−2−ヘプテン−4−イン−
3−オール+、+、7をジエチルエーテル50m1に溶
解し、塩化メタンスルホニル1.0mlとトリエチルア
ミン2.0mlを加えて水冷下に2時間撹拌する。析出
したトリエチルアミン塩酸塩を濾別し、f液に塩化メチ
レン30m1を加えて室温で24時間放置する。溶媒を
減圧留去し、得られた(E)−6−メチル−6−フェニ
ル−2−へブテン−4−イニルメタンスルホナートをヘ
キサン50m1と47%臭化水素酸45m1の混液に溶
解し、室温で3時間撹拌する。有機層を分取し、水洗、
次いで無水硫酸マグ不ノウムにより乾燥後溶媒を減圧留
去すると、無色油状の表題化合物1.1547 (収率
77%)が得られる。
1, 47 (2H, q, J-7,0Hz), 3. (
II (3)1. s), 4.72 (2H, d, J
+:6,5Hz), 5.84(IH,d, J=15
.. 5t(z) 6.11(1B, dt J=15.5
Hz, 6.5Hz) Example 3 6-methyl-6-phenyl-2-hepten-4-yn-
3-ol +, +, 7 was dissolved in 50 ml of diethyl ether, 1.0 ml of methanesulfonyl chloride and 2.0 ml of triethylamine were added, and the mixture was stirred for 2 hours under water cooling. The precipitated triethylamine hydrochloride is filtered off, and 30 ml of methylene chloride is added to solution f, and the mixture is left at room temperature for 24 hours. The solvent was distilled off under reduced pressure, and the obtained (E)-6-methyl-6-phenyl-2-hebuten-4-ynyl methanesulfonate was dissolved in a mixture of 50 ml of hexane and 45 ml of 47% hydrobromic acid. , stir at room temperature for 3 hours. Separate the organic layer, wash with water,
Then, after drying over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure to obtain the title compound 1.1547 (yield 77%) as a colorless oil.

H−NMR(CDC1,)δ: 1.60(6)1. 
s) 、 3.99 (21−1,d、 J=6.5)
1z)5、82(IH,d、 J15.5Hz)、 6
.25 (IH,dt、 J=15.5Hz、 6.5
Hz)、7.16−7.61(5H,m)光渥■と1果 かくして、本発明によれば一般式[11]で示されるア
ルコール誘導体から新規化合物である一般式[T]で示
される(E)−2−アルケン−4−イニルスルホナート
誘導体が簡便、且つ、高収率で得られ、この目的化合物
は医薬品等の製造中間体として非常に有用である。
H-NMR (CDC1,) δ: 1.60 (6) 1.
s), 3.99 (21-1, d, J=6.5)
1z) 5, 82 (IH, d, J15.5Hz), 6
.. 25 (IH, dt, J=15.5Hz, 6.5
Hz), 7.16-7.61 (5H, m) and 1.Thus, according to the present invention, a novel compound represented by the general formula [T] is obtained from the alcohol derivative represented by the general formula [11]. (E)-2-alken-4-ynylsulfonate derivatives can be obtained easily and in high yields, and this target compound is very useful as an intermediate for the production of pharmaceuticals and the like.

Claims (4)

【特許請求の範囲】[Claims] (1)一般式 ▲数式、化学式、表等があります▼[ I ] [式中、Rは低級アルキル基、フェニル基又はp−トリ
ル基を示し、R^1は水素原子、低級アルキル基、低級
アルコキシ基又はフェニル基を示し、また、R^2及び
R^3は同一若しくは異なって水素原子又は低級アルキ
ル基を示すか或いは両者が一緒になって低級アルキレン
基を示す]で表される(E)−2−アルケン−4−イニ
ルスルホナート誘導体。
(1) General formula ▲ Numerical formula, chemical formula, table, etc. ▼ [I] [In the formula, R represents a lower alkyl group, phenyl group, or p-tolyl group, and R^1 represents a hydrogen atom, a lower alkyl group, a lower represents an alkoxy group or a phenyl group, and R^2 and R^3 are the same or different and represent a hydrogen atom or a lower alkyl group, or both together represent a lower alkylene group] (E )-2-alken-4-ynylsulfonate derivatives.
(2)Rがメチル基であり、R^1、R^2及びR^3
が第1請求項と同じである(E)−2−アルケン−4−
イニルスルホナート誘導体。
(2) R is a methyl group, R^1, R^2 and R^3
(E)-2-alkene-4- which is the same as in the first claim
Inylsulfonate derivatives.
(3)一般式 ▲数式、化学式、表等があります▼[II] [式中、R^1、R^2及びR^3は第1請求項で定義
した意味を有する]で表されるアルコール誘導体に、塩
基の存在下、一般式 R−SO_2Cl[III] [式中、Rは第1請求項で定義した意味を有する]で表
される化合物を反応させて、一般式 ▲数式、化学式、表等があります▼[IV] [式中、R、R^1、R^2及びR^3は前記の意味を
有する]で表される化合物を得、次いでこれを分子内転
移させることを特徴とする第1請求項記載の一般式▲数
式、化学式、表等があります▼[ I ] [式中、R、R^1、R^2及びR^3は前記の意味を
有する]で表される(E)−2−アルケン−4−イニル
スルホナート誘導体の製造法。
(3) Alcohol represented by the general formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [II] [In the formula, R^1, R^2 and R^3 have the meanings defined in the first claim] The derivative is reacted with a compound represented by the general formula R-SO_2Cl[III] [wherein R has the meaning defined in the first claim] in the presence of a base to form the general formula ▲mathematical formula, chemical formula, There are tables etc. ▼ [IV] A method characterized by obtaining a compound represented by [wherein R, R^1, R^2 and R^3 have the above-mentioned meanings] and then intramolecularly rearranging this compound. The general formula stated in the first claim ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [I] [In the formula, R, R^1, R^2 and R^3 have the above meanings] A method for producing (E)-2-alken-4-ynylsulfonate derivatives.
(4)Rがメチル基であり、R^1、R^2及びR^3
が第3請求項と同じである第3請求項記載の(E)−2
−アルケン−4−イニルスルホナート誘導体の製造法。
(4) R is a methyl group, R^1, R^2 and R^3
(E)-2 of the third claim, where is the same as the third claim
- A method for producing an alkene-4-ynyl sulfonate derivative.
JP21852990A 1990-08-20 1990-08-20 (e)-2-alken-4-ynyl sulfonate derivative and production thereof Pending JPH0499759A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21852990A JPH0499759A (en) 1990-08-20 1990-08-20 (e)-2-alken-4-ynyl sulfonate derivative and production thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21852990A JPH0499759A (en) 1990-08-20 1990-08-20 (e)-2-alken-4-ynyl sulfonate derivative and production thereof

Publications (1)

Publication Number Publication Date
JPH0499759A true JPH0499759A (en) 1992-03-31

Family

ID=16721355

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21852990A Pending JPH0499759A (en) 1990-08-20 1990-08-20 (e)-2-alken-4-ynyl sulfonate derivative and production thereof

Country Status (1)

Country Link
JP (1) JPH0499759A (en)

Similar Documents

Publication Publication Date Title
JPH02262558A (en) New method for producing phenyl-1-diethylaminocarbonyl- 1-phthalimidomethyl-2-cyclopropane z
US4994619A (en) Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
US4408063A (en) Preparation of epihalohydrin enantiomers
JPH0499759A (en) (e)-2-alken-4-ynyl sulfonate derivative and production thereof
JPS61145174A (en) Novel optically active epoxypropionic acid ester derivative and preparation thereof
US4946974A (en) Optically active derivatives of glycidol
US5254708A (en) Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
JPS61268663A (en) Production of optically active 2-hydroxy-3,3-disubstituted propionic acid
JP3066594B2 (en) Aniline derivative and method for producing the same
US20050054877A1 (en) Enantiomerically selective cyclopropanation
US5231208A (en) Substituted cyclic ketones, substituted cyclic enones, and process for producing the same
FR2727410A1 (en) SULFONYL CHLORIDES, THEIR PREPARATION AND THEIR USE AS SYNTHESIS INTERMEDIATES
US5344947A (en) Optically active derivatives of glycidol
JP2771678B2 (en) Fluorine-containing compound and method for producing the same
SU1293167A1 (en) Method of producing cis-1-0-(1-alkenyl)-glycerin
JP2905931B2 (en) Process for producing optically active 2-cyclopentenones
JP2724634B2 (en) Optically active 1-phenylpyrrolidone derivatives, intermediates for their production, and methods for their production
JPH01100147A (en) Optically active malonic acid ester derivative
JPS6251637A (en) Production of 2-methylene-6,6-dimethyl or 5,6,6-trimethylcyclohexylcarbaldehyde
JP4064645B2 (en) New production method of polysubstituted cycloalkenes
JPS59216841A (en) Agent for optical resolution
JP2973546B2 (en) Optically active 4-benzoyloxymethyl-2-oxazolidinone and method for producing the same
JPH02237963A (en) Tropolone derivative
JP2000198775A (en) Cyclic guanidine and its production
JPH023672A (en) 2,6-diethylaniline derivative and production thereof